Newsletter | March 18, 2024

03.18.24 -- Site Feasibility Tips For Cell And Gene Therapy Clinical Trials

CLINICAL SITES

Site Feasibility Tips For CGT Clinical Trials

Guest Column | By Jessica Cordes, Clinical Excellence GmbH

Site feasibility assessment can be challenging. Therefore, it’s essential to have a solid understanding of the regulatory obligations for investigators and sites when it comes to choosing each. 

Engage Frontier Sites Without Sacrificing Compliance Or Data Integrity

Article | By Taylor Davidson, Florence Healthcare

By partnering with frontier sites, discover how sponsors and coordinating centers can make their trials more accessible and patient centric.

Driving ROI: A Patient Convenience Solution

White Paper | Greenphire

Uncover the findings from this third-party ROI analysis firm that conducted interviews with customers to assess their experiences using Greenphire's participant reimbursement and travel solutions.

The Impact Of Clinical Trial Payments On Site-Sponsor Relationships

Article | By Jim DiCesare, IQVIA Technologies

The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.

PATIENT CENTRICITY

Transforming Trials For Women In 2024

Guest Column | By Juan Camilo Arjona Ferreira, Organon

Change is long overdue, and it begins with a fundamental shift in how we design clinical trials, placing women's perspectives and needs at the core of planning and implementation.

3 Strategies For Increasing Diversity In Psychedelic Research

Article | Elligo Health Research

Psychedelic research has about 18.4% total minority participation—less than half of the average 38.2% country-level representation. Increase racial and ethnic diversity with these three proven strategies.

The Shifting Paradigm Of Dose Selection In Oncology

White Paper | By Jeffrey Keefer, MD, Ph.D., David Alsadius, MD, Ph.D., Jeffrey Hodge, and Matthew Simmons, IQVIA Biotech

Oncology drug development is undergoing a big transformation. Explore approaches for integrating dose finding and optimization into early clinical development and how it could benefit patients.

PATIENT RECRUITMENT

Addressing Underrepresentation: A Q&A With Stand Up To Cancer And Triage Cancer

Guest Column | A conversation with Stand Up To Cancer researcher Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq.

Clinical Leader heard from both sides of the collaboration — SU2C researcher Dr. Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq. — to explore each’s efforts to together bring health equity to those diagnosed with cancer.

Diversity In Patient Recruitment For Clinical Research

Webinar | Oracle Life Sciences

Does real-world data serve as the key to increasing diverse representation in clinical research? Why does technology play a pivotal role in this transformation?

The (True) Patient Journey

Infographic | Scout

For clinical trial patients, the journey and its challenges begin as soon as the first appointment is set. Discover some lesser-known pain points — and how Scout helps patients navigate them.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: